The truth about the drug companies: how they deceive us and what to do about it
Author:
Publisher:
Varies, see individual formats and editions
Publication Date:
Varies, see individual formats and editions
Language:
English
Description
During her two decades at The New England Journal of Medicine, Dr. Marcia Angell had a front-row seat on the appalling spectacle of the pharmaceutical industry. She watched drug companies stray from their original mission of discovering and manufacturing useful drugs and instead become vast marketing machines with unprecedented control over their own fortunes. She saw them gain nearly limitless influence over medical research, education, and how doctors do their jobs. She sympathized as the American public, particularly the elderly, struggled and increasingly failed to meet spiraling prescription drug prices. Now, in this bold, hard-hitting new book, Dr. Angell exposes the shocking truth of what the pharmaceutical industry has become–and argues for essential, long-overdue change.
Currently Americans spend a staggering $200 billion each year on prescription drugs. As Dr. Angell powerfully demonstrates, claims that high drug prices are necessary to fund research and development are unfounded: The truth is that drug companies funnel the bulk of their resources into the marketing of products of dubious benefit. Meanwhile, as profits soar, the companies brazenly use their wealth and power to push their agenda through Congress, the FDA, and academic medical centers.
Zeroing in on hugely successful drugs like AZT (the first drug to treat HIV/AIDS), Taxol (the best-selling cancer drug in history), and the blockbuster allergy drug Claritin, Dr. Angell demonstrates exactly how new products are brought to market. Drug companies, she shows, routinely rely on publicly funded institutions for their basic research; they rig clinical trials to make their products look better than they are; and they use their legions of lawyers to stretch out government-granted exclusive marketing rights for years. They also flood the market with copycat drugs that cost a lot more than the drugs they mimic but are no more effective.
The American pharmaceutical industry needs to be saved, mainly from itself, and Dr. Angell proposes a program of vital reforms, which includes restoring impartiality to clinical research and severing the ties between drug companies and medical education. Written with fierce passion and substantiated with in-depth research, The Truth About the Drug Companies is a searing indictment of an industry that has spun out of control.
Currently Americans spend a staggering $200 billion each year on prescription drugs. As Dr. Angell powerfully demonstrates, claims that high drug prices are necessary to fund research and development are unfounded: The truth is that drug companies funnel the bulk of their resources into the marketing of products of dubious benefit. Meanwhile, as profits soar, the companies brazenly use their wealth and power to push their agenda through Congress, the FDA, and academic medical centers.
Zeroing in on hugely successful drugs like AZT (the first drug to treat HIV/AIDS), Taxol (the best-selling cancer drug in history), and the blockbuster allergy drug Claritin, Dr. Angell demonstrates exactly how new products are brought to market. Drug companies, she shows, routinely rely on publicly funded institutions for their basic research; they rig clinical trials to make their products look better than they are; and they use their legions of lawyers to stretch out government-granted exclusive marketing rights for years. They also flood the market with copycat drugs that cost a lot more than the drugs they mimic but are no more effective.
The American pharmaceutical industry needs to be saved, mainly from itself, and Dr. Angell proposes a program of vital reforms, which includes restoring impartiality to clinical research and severing the ties between drug companies and medical education. Written with fierce passion and substantiated with in-depth research, The Truth About the Drug Companies is a searing indictment of an industry that has spun out of control.
More Copies In LINK+
Loading LINK+ Copies...
Subjects
Subjects
Advertising
Advertising -- Drugs -- United States
Business
Costs
Drugs
Drugs -- Prices -- United States
Drugs -- Research -- United States -- Finance
Economics
Finance
Nonfiction
Pharmaceutical industry
Pharmaceutical industry -- United States -- Costs
Pharmaceutical policy
Pharmaceutical policy -- United States
Prescription pricing
Prescription pricing -- United States
Prices
Research
Advertising -- Drugs -- United States
Business
Costs
Drugs
Drugs -- Prices -- United States
Drugs -- Research -- United States -- Finance
Economics
Finance
Nonfiction
Pharmaceutical industry
Pharmaceutical industry -- United States -- Costs
Pharmaceutical policy
Pharmaceutical policy -- United States
Prescription pricing
Prescription pricing -- United States
Prices
Research
More Details
ISBN:
9780375760945
9780375508462
9781588362117
9780375508462
9781588362117
Reviews from GoodReads
Loading GoodReads Reviews.
Staff View
QR Code
Grouping Information
Grouped Work ID | 1e7986ee-4f1b-642a-3f65-b7eab1fe71e3 |
---|---|
Grouping Title | truth about the drug companies how they deceive us and what to do about it |
Grouping Author | marcia angell |
Grouping Category | book |
Grouping Language | English (eng) |
Last Grouping Update | 2024-09-07 02:15:45AM |
Last Indexed | 2024-09-07 02:27:38AM |
Solr Fields
accelerated_reader_point_value
0
accelerated_reader_reading_level
0
author
Angell, Marcia
author_display
Angell, Marcia
available_at_catalog
Carmichael
Central
Central
detailed_location_catalog
Carmichael
Central
Central
display_description
During her two decades at The New England Journal of Medicine, Dr. Marcia Angell had a front-row seat on the appalling spectacle of the pharmaceutical industry. She watched drug companies stray from their original mission of discovering and manufacturing useful drugs and instead become vast marketing machines with unprecedented control over their own fortunes. She saw them gain nearly limitless influence over medical research, education, and how doctors do their jobs. She sympathized as the American public, particularly the elderly, struggled and increasingly failed to meet spiraling prescription drug prices. Now, in this bold, hard-hitting new book, Dr. Angell exposes the shocking truth of what the pharmaceutical industry has become–and argues for essential, long-overdue change.
Currently Americans spend a staggering $200 billion each year on prescription drugs. As Dr. Angell powerfully demonstrates, claims that high drug prices are necessary to fund research and development are unfounded: The truth is that drug companies funnel the bulk of their resources into the marketing of products of dubious benefit. Meanwhile, as profits soar, the companies brazenly use their wealth and power to push their agenda through Congress, the FDA, and academic medical centers.
Zeroing in on hugely successful drugs like AZT (the first drug to treat HIV/AIDS), Taxol (the best-selling cancer drug in history), and the blockbuster allergy drug Claritin, Dr. Angell demonstrates exactly how new products are brought to market. Drug companies, she shows, routinely rely on publicly funded institutions for their basic research; they rig clinical trials to make their products look better than they are; and they use their legions of lawyers to stretch out government-granted exclusive marketing rights for years. They also flood the market with copycat drugs that cost a lot more than the drugs they mimic but are no more effective.
The American pharmaceutical industry needs to be saved, mainly from itself, and Dr. Angell proposes a program of vital reforms, which includes restoring impartiality to clinical research and severing the ties between drug companies and medical education. Written with fierce passion and substantiated with in-depth research, The Truth About the Drug Companies is a searing indictment of an industry that has spun out of control.
Currently Americans spend a staggering $200 billion each year on prescription drugs. As Dr. Angell powerfully demonstrates, claims that high drug prices are necessary to fund research and development are unfounded: The truth is that drug companies funnel the bulk of their resources into the marketing of products of dubious benefit. Meanwhile, as profits soar, the companies brazenly use their wealth and power to push their agenda through Congress, the FDA, and academic medical centers.
Zeroing in on hugely successful drugs like AZT (the first drug to treat HIV/AIDS), Taxol (the best-selling cancer drug in history), and the blockbuster allergy drug Claritin, Dr. Angell demonstrates exactly how new products are brought to market. Drug companies, she shows, routinely rely on publicly funded institutions for their basic research; they rig clinical trials to make their products look better than they are; and they use their legions of lawyers to stretch out government-granted exclusive marketing rights for years. They also flood the market with copycat drugs that cost a lot more than the drugs they mimic but are no more effective.
The American pharmaceutical industry needs to be saved, mainly from itself, and Dr. Angell proposes a program of vital reforms, which includes restoring impartiality to clinical research and severing the ties between drug companies and medical education. Written with fierce passion and substantiated with in-depth research, The Truth About the Drug Companies is a searing indictment of an industry that has spun out of control.
format_catalog
Book
eBook
eBook
format_category_catalog
Books
eBook
eBook
id
1e7986ee-4f1b-642a-3f65-b7eab1fe71e3
isbn
9780375508462
9780375760945
9781588362117
9780375760945
9781588362117
itype_catalog
Adult Book Non-Fiction
last_indexed
2024-09-07T09:27:38.060Z
lexile_score
-1
literary_form
Non Fiction
literary_form_full
Non Fiction
local_callnumber_catalog
338.436151 A583 2004
owning_library_catalog
Sacramento Public Library
owning_location_catalog
Carmichael
Central
Central
primary_isbn
9780375760945
publishDate
2004
publisher
Random House
Random House Publishing Group
Random House Publishing Group
recordtype
grouped_work
subject_facet
Advertising -- Drugs -- United States
Drugs -- Prices -- United States
Drugs -- Research -- United States -- Finance
Pharmaceutical industry -- United States -- Costs
Pharmaceutical policy -- United States
Prescription pricing -- United States
Drugs -- Prices -- United States
Drugs -- Research -- United States -- Finance
Pharmaceutical industry -- United States -- Costs
Pharmaceutical policy -- United States
Prescription pricing -- United States
title_display
The truth about the drug companies : how they deceive us and what to do about it
title_full
The Truth About the Drug Companies How They Deceive Us and What to Do About It
The truth about the drug companies : how they deceive us and what to do about it / Marcia Angell
The truth about the drug companies : how they deceive us and what to do about it / Marcia Angell
title_short
The truth about the drug companies
title_sub
how they deceive us and what to do about it
topic_facet
Advertising
Business
Costs
Drugs
Economics
Finance
Nonfiction
Pharmaceutical industry
Pharmaceutical policy
Prescription pricing
Prices
Research
Business
Costs
Drugs
Economics
Finance
Nonfiction
Pharmaceutical industry
Pharmaceutical policy
Prescription pricing
Prices
Research
Solr Details Tables
item_details
Bib Id | Item Id | Shelf Location | Call Num | Format | Format Category | Num Copies | Is Order Item | Is eContent | eContent Source | eContent URL | Detailed Status | Last Checkin | Location |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ils:.b1707437x | .i85342658 | Central | 338.436151 A583 2004 | 1 | false | false | On Shelf | cenag | |||||
ils:.b1707437x | .i45886933 | Carmichael | 338.436151 A583 2004 | 1 | false | false | On Shelf | carag | |||||
overdrive:d564e011-9a96-4bdf-b9a8-e078c6c71095 | -2 | Online OverDrive Collection | Online OverDrive | eBook | eBook | 1 | false | true | OverDrive | Checked Out |
record_details
Bib Id | Format | Format Category | Edition | Language | Publisher | Publication Date | Physical Description | Abridged |
---|---|---|---|---|---|---|---|---|
ils:.b1707437x | Book | Books | 1st ed | English | Random House | c2004 | xx, 305 p. ; 25 cm. | |
overdrive:d564e011-9a96-4bdf-b9a8-e078c6c71095 | eBook | eBook | English | Random House Publishing Group | 2004 |
scoping_details_catalog
Bib Id | Item Id | Grouped Status | Status | Locally Owned | Available | Holdable | Bookable | In Library Use Only | Library Owned | Holdable PTypes | Bookable PTypes | Local Url |
---|---|---|---|---|---|---|---|---|---|---|---|---|
ils:.b1707437x | .i85342658 | On Shelf | On Shelf | false | true | true | true | false | true | 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 15, 18, 19, 20, 22, 24, 26, 31, 32, 33, 34, 36, 37, 38, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120 | 11 | |
ils:.b1707437x | .i45886933 | On Shelf | On Shelf | false | true | true | true | false | true | 0, 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 15, 18, 19, 20, 22, 24, 26, 31, 32, 33, 34, 36, 37, 38, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 111, 112, 113, 114, 115, 116, 117, 118, 119, 120 | 11 | |
overdrive:d564e011-9a96-4bdf-b9a8-e078c6c71095 | -2 | Checked Out | Checked Out | false | false | true | false | false | false |